Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas M Silverstein

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Nature Clinical Practice. Nephrology|August 26, 2006
Does pravastatin safely and effectively improve lipid profiles in children who have received a kidney transplant?Douglas M Silverstein
Frontiers in Pediatrics|August 30, 2018
Growth and Nutrition in Pediatric Chronic Kidney DiseaseDouglas M Silverstein
Pediatric Transplantation|February 13, 2003
Indications and outcome of treatment of hyperlipidemia in pediatric allograft recipientsDouglas M Silverstein
Pediatric Nephrology (Berlin, Germany)|April 12, 2017
Frequent hemodialysis: history of the modality and assessment of outcomesDouglas M Silverstein
Pediatric Transplantation|July 22, 2004
Risk factors for cardiovascular disease in pediatric renal transplant recipientsDouglas M Silverstein
Pediatric Nephrology (Berlin, Germany)|December 17, 2008
Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular diseaseDouglas M Silverstein
Clinical Pediatrics|April 20, 2004
Enuresis in children: diagnosis and managementDouglas M Silverstein
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 27, 2010
Cause and outcome of central venous catheter infections in paediatric haemodialysis patientsDouglas M Silverstein, Kathleen Moylan
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Presenting features and short-term outcome according to pathologic variant in childhood primary focal segmental glomerulosclerosisDouglas M Silverstein, Randall Craver
Pediatric Nephrology (Berlin, Germany)|March 25, 2015
Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal diseaseMona Khurana, Douglas M Silverstein
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Nature Clinical Practice. Nephrology|August 26, 2006
Does pravastatin safely and effectively improve lipid profiles in children who have received a kidney transplant?Douglas M Silverstein
Frontiers in Pediatrics|August 30, 2018
Growth and Nutrition in Pediatric Chronic Kidney DiseaseDouglas M Silverstein
Pediatric Transplantation|February 13, 2003
Indications and outcome of treatment of hyperlipidemia in pediatric allograft recipientsDouglas M Silverstein
Pediatric Nephrology (Berlin, Germany)|April 12, 2017
Frequent hemodialysis: history of the modality and assessment of outcomesDouglas M Silverstein
Pediatric Transplantation|July 22, 2004
Risk factors for cardiovascular disease in pediatric renal transplant recipientsDouglas M Silverstein
Pediatric Nephrology (Berlin, Germany)|December 17, 2008
Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular diseaseDouglas M Silverstein
Clinical Pediatrics|April 20, 2004
Enuresis in children: diagnosis and managementDouglas M Silverstein
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 27, 2010
Cause and outcome of central venous catheter infections in paediatric haemodialysis patientsDouglas M Silverstein, Kathleen Moylan
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Presenting features and short-term outcome according to pathologic variant in childhood primary focal segmental glomerulosclerosisDouglas M Silverstein, Randall Craver
Pediatric Nephrology (Berlin, Germany)|March 25, 2015
Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal diseaseMona Khurana, Douglas M Silverstein
Pageof 5